Screener
BOUT vs BFRZ
Innovator IBD Breakout Opportunities ETF vs Innovator Equity Managed 100 Buffer ETF
Key differences
- BOUT costs 0.09% less per year.
- BFRZ is significantly larger than BOUT — larger funds tend to be more liquid and less likely to close.
- BOUT has a longer track record, which may reduce uncertainty around long-term behavior.
Side-by-side comparison
| BOUT | BFRZ | |
|---|---|---|
| Annual cost (TER) | 0.80% | 0.89% |
| Fund size (AUM) | $16M | $124M |
| Since | 2018 | 2025 |
| Dividend yield | 0.28% | — |
| Asset class | alternative | alternative |
| Region | north america | north america |
| Strategy | structured outcome | structured outcome |
| CAGR 1Y | +36.1% | +8.4% |
| CAGR 3Y | +17.0% | N/A |
| CAGR 5Y | +8.8% | N/A |
| Sharpe 3Y | 0.74 | N/A |
| Volatility 1Y | 20.75% | 4.97% |
| Max drawdown | -36.75% | -3.12% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to BOUT and BFRZ
Explore further